Geneco Groupsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-06-16
Share capital
5 000,00 PLN
Activity description

Geneco Group is a call center that specializes in providing services for the pharmaceutical market. They aim to increase sales of pharmaceutical products, build customer loyalty, and reduce customer outreach costs.

Registered address
ul. Kpt. Pilota Żwirki 1C/4d, 90-448 Łódź, Poland
Website
genecocontact.plWebsite active
Email
Email address current
Phone
Social media

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 156.22kMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD -23.91kMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 178.56kMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 21.53kMedianUSD 539.29kAverageUSD 10.66m

Bank accounts

Registered as a VAT taxpayer on 2017-07-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

4 public aid cases recorded, with a total value of $12,794.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$442
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$10,431
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$639

Tenders

No recorded participation in tenders.

Authorized Representatives

Jarosław Weiss — President of the Management Board

Manner of representation

In the event that a multi-member management board is appointed, each member of the management board is authorized to make declarations concerning the company’s property rights and obligations, represent the company and sign documents on its behalf independently.

Ownership

OwnerSharesShare valueStake
Mateusz Jarosław Weiss (26)
95$1,283.0995%
Others
5$67.535%

Beneficial owners

Person
Mateusz Jarosław Weiss (26)

Competitors

Name
Market-Placesp. z o.o.
Biocomsp. z o.o.
Centergensp. z o.o.
En-Brokersp. z o.o.
Toto Pharma Polandsp. z o.o.
EDGE Pharmasp. z o.o.

Change history

DateEvent
2022-08-08Address change
2017-06-16Entered in the register

FAQ

Last updated: 2026-04-23